(2018). Evolution of regenerative medicine business models. Clinical Therapeutics, 40(7), 1084-1094, . http://doi.org/10.1016/j.clinthera.2018.06.003.
(2013). Finance as a ‘forgotten technological capability’ for promoting African local pharmaceutical manufacture. International Journal Of Technology Management And Sustainable Development, 12(2), 117-135, . Retrieved from http://oro.open.ac.uk/38594/.
(2015). Pharmaceutical Standards in Africa: The Road to Improvement and Their Role in Technological Capability Upgrading. In Making Medicines in Africa: The Political Economy of Industrializing for Local Health (pp. 224-242, ). Palgrave Macmillan. Retrieved from http://www.palgrave.com/page/detail/making-medicines-in-africa-maureen-mackintosh/?isb=9781137546463.
(2018). Health-industry linkages for local health: reframing policies for African health system strengthening. Health Policy And Planning, 33(4), 602-610, . Retrieved from https://academic.oup.com/heapol/article/33/4/602/4942503?guestAccessKey=64542eaf-2e56-4e0c-8758-261cec752018.
(2017). Local production of pharmaceuticals and health system strengthening in Africa: An Evidence Brief. Berlin: German Health Practice Collection (GHPC). Retrieved from http://www.health.bmz.de/ghpc/evidence_briefs/local_production_pharmaceuticals_health_system_strengthening_africa/index.html.
(2017). Private Sector Participation in Health Care in Zimbabwe: What’s the Value Added and Institutional Challenges?. Journal Of Healthcare Communications, 2(2). Retrieved from http://oro.open.ac.uk/48668/.
(2017). Proportionate and adaptive governance of innovative technologies (PAGIT). Proportionate and adaptive governance of innovative technologies (PAGIT). Edinburgh: Innogen Institute Report..
(2016). Proportionate and Adaptive Governance of Innovative Technologies. Proportionate and Adaptive Governance of Innovative Technologies. London: BSI Standards Ltd..
(2017). Private sector participation in health care in Zimbabwe. Journal Of Healthcare Communications, 2(2). http://doi.org/10.4172/2472-1654.100050.
(2019). Understanding the emergence and evolution of new business models in the UK regenerative medicine sector. Technology Analysis And Strategic Management. http://doi.org/10.1080/09537325.2019.1685087.